Home

Resa rem servitören reuters teva Rådfråga Rökelse Bostad

Teva's $420mn investor settlement to be mostly covered by insurers | The  Insurer
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer

Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva, Texas strike opioid settlement worth $225M | Business Insurance

Teva, Texas strike opioid settlement worth $225 million - The Jerusalem Post
Teva, Texas strike opioid settlement worth $225 million - The Jerusalem Post

Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva and Eli Lilly scrap over migraine drug rights — MedWatch

What's 'down' with Teva? - Israel News - The Jerusalem Post
What's 'down' with Teva? - Israel News - The Jerusalem Post

Teva Pharmaceutical Is in Recovery - WSJ
Teva Pharmaceutical Is in Recovery - WSJ

Teva Pharm to stay as unified drugmaker, sees big interest in API business,  says CEO | Reuters
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters

Teva Pharmaceutical | PBS NewsHour
Teva Pharmaceutical | PBS NewsHour

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case |  Reuters
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters

Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend

Teva, armed with 2 recent launches, raises revenue guidance
Teva, armed with 2 recent launches, raises revenue guidance

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters

Drug-maker Teva fueled opioid addiction in NY, jury finds | Business  Insurance
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance

Teva to pay up to $523 million to New York state to settle opioid suit |  Business Insurance
Teva to pay up to $523 million to New York state to settle opioid suit | Business Insurance

Teva to pay $85m to Oklahoma over opioid case
Teva to pay $85m to Oklahoma over opioid case

Exclusive: CVS to Cover Migraine Drugs From Teva, Lilly; Excludes Amgen
Exclusive: CVS to Cover Migraine Drugs From Teva, Lilly; Excludes Amgen

Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ

Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters

Teva Pharm to stay as unified drugmaker, sees big interest in API business,  says CEO | Reuters
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters

Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

US court invalidates key TEVA drug patent
US court invalidates key TEVA drug patent

Biden admin urges Supreme Court to hear 'skinny labels' case between Teva,  GSK | Reuters
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters